"Overall vacancy increased to 28.4%, rising 750 basis points (bps) year over year. Direct vacancy climbed 780 bps from the prior year to 23.2%, while sublease vacancy edged down by 40 bps year over year to 5.2%."

"Overall vacancy stands at 36.6%, representing a 210- basis-points (bps) decrease from last quarter’s 38.7%. Despite this quarterly decline, vacancy has increased by 460 bps year over year. "

"Overall vacancy stands at 27.1%, down 40 basis points (bps) from 27.5% year over year, while available space also declined slightly from 1.5 million square feet (msf) to 1.4 msf over the same period. "

"Vacancy declined modestly to 31.8%, down 190 basis points (bps) from 33.7% in Q4 2024. Even so, more than a quarter of New York City’s life sciences inventory remains vacant, indicating continued softness in tenant demand."

"Overall vacancy stands at 7.2%, representing a 110-basis point (bp) increase year-over-year. Direct vacancy remains at 6.5%, unchanged from last quarter and among the highest levels recorded in the market."

"Overall vacancy increased modestly to 22.2% from 20.4% in Q4 2022, while sublease vacancy rose by 120 basis points (bps) year over year to 3.6% from 2.4%."

"Overall vacancy increased 61.6% year over year to 28.6%, driven in part by the delivery of more than 3 million square feet of new life sciences space added to the market."

"Vacancy increased 210 basis points (bps) from Q4 2024 to 24.3%, driven by a rise in direct vacancy to 20.1%. Sublease vacancy edged down to 4.2%, marking its lowest level since Q4 2024. "

"Overall vacancy stands at 17.5%, up 260 basis points (bps) from last year. Direct vacancy continues to rise as it is currently at 15.8%, up 350 bps since Q4 2024, while sublease vacancy has fallen to its lowest level since 2023."

"Vacancy increased by 120 basis points (bps) from Q4 2024 to 15.3%, driven by rising sublease availability. Sublease vacancy climbed to 2.5%, up from 1.7% in Q4 2024, contributing to the increase in overall vacancy."